Weighted Average Number of Shares Outstanding, Diluted of CITIUS ONCOLOGY, INC. from Q2 2022 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CITIUS ONCOLOGY, INC. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2022 to Q2 2025.
  • CITIUS ONCOLOGY, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2025 was 71.6M shares, a 6% increase year-over-year.
  • CITIUS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 68.1M shares, a 931% increase from 2023.
  • CITIUS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.6M shares, a 392% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 71.6M +4.05M +6% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 71.6M +4.05M +6% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 71.6M +4.05M +6% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 68.1M +61.5M +931% 01 Jul 2024 30 Sep 2024 10-K 27 Dec 2024
Q2 2024 67.5M +60.9M +923% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 67.5M +60.9M +923% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 67.5M 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025
Q3 2023 6.6M +5.1M +340% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 6.6M +5.1M +340% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 6.6M 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024
Q3 2022 1.5M 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 1.5M 01 Apr 2022 30 Jun 2022 10-Q 16 Aug 2023

CITIUS ONCOLOGY, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 68.1M +61.5M +931% 01 Oct 2023 30 Sep 2024 10-K 27 Dec 2024
2023 6.6M +5.26M +392% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024
2022 1.34M 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.